First-Line Nivolumab + Ipilimumab in Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small Cell Lung Cancer: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
J Thorac Oncol 2021 Oct 11;[EPub Ahead of Print], LG Paz-Ares, SS Ramalingam, TE Ciuleanu, JS Lee, L Urban, RB Caro, K Park, H Sakai, Y Ohe, M Nishio, C Audigier-Valette, JA Burgers, A Pluzanski, R Sangha, C Gallardo, M Takeda, H Linardou, L Lupinacci, KH Lee, C Caserta, M Provencio, E Carcereny, GA Otterson, M Schenker, B Zurawski, A Alexandru, A Vergnenegre, J Raimbourg, K Feeney, SW Kim, H Borghaei, KJ O'Byrne, MD Hellmann, A Memaj, FE Nathan, J Bushong, P Tran, JR Brahmer, M ReckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.